🇫🇷 France Country × Condition
lung cancer Clinical Trials in France
Active clinical trials for lung cancer with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇫🇷 France
Active Trials in France (5)
NCT06481813
Recruiting
Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
Enrollment
730 pts
Country
🇫🇷 France
Nantes University Hospital
View Trial → NCT06923774
Recruiting
European Real-World Registry for Use of the Ion Endoluminal System
Enrollment
1,200 pts
Country
🇫🇷 France
Intuitive Surgical
View Trial → NCT05983432 Phase 1
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Enrollment
470 pts
Country
🇫🇷 France
SystImmune Inc.
View Trial → NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Enrollment
410 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → NCT04300062
Recruiting
Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer
Enrollment
50 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → Frequently Asked Questions
How many lung cancer clinical trials are active in France?
There are currently 5 active clinical trials for lung cancer with sites in France, of which 5 are actively recruiting patients.
How can I join a lung cancer clinical trial in France?
To join a lung cancer clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are lung cancer trials in France?
Active lung cancer trials in France span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology